Company: PTHL
Filing Date: 2025-11-10
Form Type: 6-K
Source: 0001213900-25-107871
Chunk: 1

Company: Pheton Holdings Ltd
Filing Date: 2025-11-10
Form: 6-K
Chunk 1
---
, a technology company. He also served as an alternate director of Hin Fah Medical Company Limited,
a company engaged in the sale of traditional Chinese medicine, from September 2012 to May 2024.

The Company believes that Mr. Richard Wee Yong
Seow qualifies as an independent director of the Company in accordance with Nasdaq Listing Rules and regulations of the Securities and
Exchange Commission (“SEC”), and Mr. Swee Leng Seng qualifies as an “audit committee financial expert” under SEC
regulations.

In connection with Mr. Seow’s appointment,
the Company has entered into an indemnification agreement with Mr. Seow.

<div align='center'>1</div>

Exhibits

| Exhibit No. |     | Description                                                                         |
| 4.1         |     | Form of Indemnification Agreement, entered by and between Mr. Seow and the Company. |

<div align='center'>2

SIGNATURES</div>

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Date: November 10, 2025 | Pheton Holdings Ltd 
 By:                 | /s/ Jianfei Zhang                                              |
|:------------------------|:--------------------|:---------------------------------------------------------------|
|                         | Name:               | Jianfei Zhang                                                  |
|                         | Title:              | Chief Executive Officer and Chairman of the Board of Directors |

<div align='center'>3</div>